Back to Results
First PageMeta Content
Natalizumab / Biogen Idec / Pharmacology / Medical prescription / Progressive multifocal leukoencephalopathy / Medicine / Health / Immunosuppressants


TYSABRI® RISK MINIMIZATION ACTION PLAN: SUMMARY OF TOUCHSM
Add to Reading List

Open Document

File Size: 54,89 KB

Share Result on Facebook
UPDATE